MRMichael Rubsamen

Michael Rubsamen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael Rubsamen has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A cross-sectional study evaluating the accuracy of International Classification of Diseases Codes for classifying firearm injury intent

    by Taylor M. Kaser, Daphne Lew, James Lappin, Michael Rubsamen, Lindsay M. Kranker, Nick Szoko, Marina Eguchi Inaba, Jacqueline Garcia, Lauren Everett, Evan Mihalakakos, et al.

  • Open Access

    NK cell dysregulation may potentiate cardiovascular disease in adolescents with perinatally acquired HIV on antiretroviral therapy

    by Mario Alles, Manuja Gunasena, Aaren Kettelhut, Kate Ailstock, Victor Musiime, Cissy Kityo, Brian Richardson, Will Mulhern, Banumathi Tamilselvan, Michael Rubsamen, et al.

    Perinatally acquired HIV (PHIV) and antiretroviral therapy (ART) can alter innate immune cells, (monocytes and natural killer [NK] cells) which are important in the pathogenesis of cardiovascular disease (CVD). We compare cardiovascular biomarkers and immune signatures between adolescents with PHIV (APHIV) on suppressive ART and HIV-unexposed, adolescents without HIV in Uganda. Carotid intima-media thickness (IMT) is increased in APHIV, suggesting a higher CVD risk. Flow cytometry analysis reveals greater activation, memory, and migratory capabilities of NK cells, and increased pro-inflammatory intermediate monocytes in APHIV, and these observations are supported by transcriptomics. Many of these innate immune cell subsets are associated with carotid IMT. Plasma oxidized-LDL (Ox-LDL) is significantly lower among APHIV, and negatively correlates with pro-inflammatory, memory-like NK subsets. We demonstrate increased uptake of Ox-LDL by macrophages in the presence of activated, memory-like NK cells in vitro, suggesting a possible mechanism for greater CVD risk in APHIV. Collectively, our data demonstrate associations between dysregulated NK cell signatures and increased CVD risk among APHIV.

  • Open Access

    Adjuvant AS01 activates human monocytes for costimulation and systemic inflammation

    by Carson L. Smith, Brian Richardson, Michael Rubsamen, Mark J. Cameron, Cheryl M. Cameron, David H. Canaday


  • Open Access

    Activated NK Cells with Pro-inflammatory Features are Associated with Atherogenesis in Perinatally HIV-Acquired Adolescents

    by Mario Alles, Manuja Gunasena, Aaren Kettelhut, Kate Ailstock, Victor Musiime, Cissy Kityo, Brian Richardson, Will Mulhern, Banumathi Tamilselvan, Michael Rubsamen, et al.

    Human immunodeficiency virus (HIV) is associated with persistent immune activation and dysfunction in people with HIV despite treatment with antiretroviral therapy (ART). Modulation of the immune system may be driven by: low-level HIV replication, co-pathogens, gut dysbiosis /translocation, altered lipid profiles, and ART toxicities. In addition, perinatally acquired HIV (PHIV) and lifelong ART may alter the development and function of the immune system. Our preliminary data and published literature suggest reprogramming innate immune cells may accelerate aging and increase the risk for future end-organ complications, including cardiovascular disease (CVD). The exact mechanisms, however, are currently unknown. Natural killer (NK) cells are a highly heterogeneous cell population with divergent functions. They play a critical role in HIV transmission and disease progression in adults. Recent studies suggest the important role of NK cells in CVDs; however, little is known about NK cells and their role in HIV-associated cardiovascular risk in PHIV adolescents. Here, we investigated NK cell subsets and their potential role in atherogenesis in PHIV adolescents compared to HIV-negative adolescents in Uganda. Our data suggest, for the first time, that activated NK subsets in PHIV adolescents may contribute to atherogenesis by promoting plasma oxidized low-density lipoprotein (Ox-LDL) uptake by vascular macrophages.